Vivesto Stock

Vivesto P/B

The P/B (Price-to-Book Ratio) of Vivesto (VIVE.ST) as of Aug 10, 2026 is 0.46. In the previous year, P/B (Price-to-Book Ratio) was 0.28 — a change of 64.52% (higher).

P/B

0.46

YoY

64.52%

Last updated:

P/B (Price-to-Book Ratio) of Vivesto is 2026 0.46 . P/B (Price-to-Book Ratio) of Vivesto was 2025 0.28 . It decreases by 64.52% higher compared to the previous year.
Access this data via the Eulerpool API

Vivesto Stock analysis

What does Vivesto do? Oasmia Pharmaceutical AB is a Swedish pharmaceutical company that specializes in the development and marketing of innovative cancer and pain medications. The company was founded in 1998 and is headquartered in Uppsala, Sweden. Vivesto is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Vivesto stock

P/B (Price-to-Book Ratio) of Vivesto is 0.46 in 2026.

P/B (Price-to-Book Ratio) of Vivesto changed from 0.28 to 0.46, representing a 64.52% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of P/B (Price-to-Book Ratio) Vivesto since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Book ratio compares a company's market price to its book value. A low P/B may indicate an undervalued stock, while a high P/B could suggest overvaluation or strong growth expectations.

P/B = Stock Price / Book Value per Share

To evaluate P/B (Price-to-Book Ratio)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for P/B (Price-to-Book Ratio).

A 'good' varies by industry and company stage. On Eulerpool, you can compare P/B (Price-to-Book Ratio)'s Vivesto with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — Vivesto

All Key Metrics — Vivesto